Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of TAP, QL, or ESP Block for Elective Cesarean Section
NCT03695172Phase 4Terminated
- Sponsor
- Duke University
- Start
- Sep 2019
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in postoperative pain, sponsored by Duke University. Started Sep 2019; status: terminated.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03695172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03695172.